Novaflupad 503 vaccine

The Novaflupad 503 vaccine is based on the latest highly pathogenic avian influenza viruses circulating in Iran and the Middle East (clade 2.3.4.4b), the most important strain of which is currently H5N1, and  It has the highest antigenic similarity to the current pathogenic viruses in the country. Therefore, it is used to prevent highly pathogenic avian influenza, especially the H5N1 strain, in brood, mother and laying hen flocks.

The Novaflupad 503 vaccine contains inactivated (killed) influenza virus H5N3 strain (A/Avian/Iran/38AMA/2019RG) Clade 2.3.4.4b at a dose of at least 1024 HAU (10log2≤H5), which is formulated in combination with an oil adjuvant as a potent antibody inducer.

 
 

 

How to use:

  • Inject 0.5 ml (one dose) under the skin of the neck or intramuscularly into the chest of healthy birds three weeks of age and older. A booster injection is recommended 3 to 4 weeks after the first injection.
  • If necessary, a booster dose should be administered 6 months after the second dose.
  • The vaccination program should be completed four weeks before the start of laying.
  • Before use, bring the contents of the bottle to room temperature and shake thoroughly.

Packaging: 500 ml bottles (1000 doses).

Storage temperature: 2 to 8 degrees Celsius (protect from freezing).

Warning: In case of accidental injection, consult a doctor immediately.

نوا واکسن راد

آدرس: استان البرز، نظرآباد، شهرک صنعتی سپهر، بلوار کارآفرینان، خیابان بهمن غربی، مرکز رشد بهنود فارمد

تلفن: 45334191 026

آخرین رویدادها
آخرین مقالات
شبکه های اجتماعی

تمامی مطالب و حقوق وبسایت متعلق به شرکت نوا واکسن راد میباشد. ® 2025

طراحی شده توسط دروازه دنیای خیال